Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
invion
Healthcare Stocks Tech Stocks Technology
Invion (ASX:IVX) Surges 20% on Non-Dilutive Funding for Cancer Program
Invion Secures Non-Dilutive Backing to Advance Cancer Therapy Invion (ASX:IVX) saw a sharp rerating today, with the share price rising 20% following the announcement of potential non-dilutive funding that meaningfully changes the near-term risk profile of the business. Rather than issuing new shares to advance its oesophageal cancer program, Hanlim Pharm will fund the required preclinical…
December 23, 20250Comments
goodman
Market news Tech Stocks Technology
Goodman Group (ASX:GMG) Strikes A$14B Data Centre Deal with CPP Investments
Goodman Partners with CPP Investments Goodman Group (ASX:GMG) rose 6% this morning following the announcement of a strategic agreement with CPP Investments to establish a 50:50 European data centre development partnership with an indicative scale of A$14B. The initial capital commitment totals A$3.9B and will fund four projects across Frankfurt, Amsterdam and Paris, delivering 435 MW…
December 23, 20250Comments
nextdc
Blue Chip Stocks Market news Tech Stocks Technology
NEXTDC or Coreweave, which is the better long-term Investment
Two Roads to Data Dominance Many investors, particularly those focused on growth and technology, already understand that data and the infrastructure supporting it have become a core driver of long term value creation. We agree with that view, but we think the more interesting question now is where that value ultimately compounds most effectively. In Australia,…
December 22, 20250Comments
Telix Pharmaceuticals
Healthcare Stocks Tech Stocks Technology
Is Telix Pharmaceuticals (ASX:TLX) Now Undervalued With Phase 3 China Clinical Success?
Why Telix Pharmaceuticals Pullback Could Be a Second Chance Telix Pharmaceuticals (ASX:TLX) has faced a challenging year, particularly for a company that previously delivered consistently strong growth. Disclosure issues and delays around FDA progress for its brain cancer imaging asset have clearly weighed on sentiment and reset near term expectations. As a result, the stock…
December 22, 20250Comments
Great Northern Minerals
Market news Mining Stocks
Great Northern Minerals (ASX:GNM) Soars on 7.1% Antimony Hit at Catalyst Ridge
Great Northern Minerals Surges 15% on High-Grade Antimony Discovery Great Northern Minerals (ASX: GNM) has surged 15% today following strong news from its Catalyst Ridge project, which hosts antimony and rare earth mineralisation. The announcement focused on the discovery of an antimony sulphide vein extending over a 1 km strike length, with vein widths ranging…
December 19, 20250Comments

Independent ASX research and stock analysis. Actionable investment ideas on ASX-listed stocks from analysts who call it straight.

Sectors
Quick Links
Learn

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here